| review article | Q7318358 |
| scholarly article | Q13442814 |
| P50 | author | Enrico Granieri | Q42246383 |
| P2093 | author name string | Carlo Contini | |
| Enrico Fainardi | |||
| Massimiliano Castellazzi | |||
| Silva Seraceni | |||
| Rosario Cultrera | |||
| P2860 | cites work | Incidence of Dementia, Alzheimer's Disease, and Vascular Dementia in Italy. The ILSA Study | Q22250949 |
| Genetics of austim: complex aetiology for a heterogeneous disorder | Q22251288 | ||
| PCR in diagnosis of infection: detection of bacteria in cerebrospinal fluids | Q24531865 | ||
| Failure to detect Chlamydia pneumoniae in brain sections of Alzheimer's disease patients | Q24551398 | ||
| Detection of Chlamydia in the peripheral blood cells of normal donors using in vitro culture, immunofluorescence microscopy and flow cytometry techniques | Q25255988 | ||
| Emended description of the order Chlamydiales, proposal of Parachlamydiaceae fam. nov. and Simkaniaceae fam. nov., each containing one monotypic genus... | Q28143578 | ||
| Multiple co-infections (Mycoplasma, Chlamydia, human herpes virus-6) in blood of chronic fatigue syndrome patients: association with signs and symptoms | Q28190424 | ||
| Autistic disorder and viral infections | Q28243027 | ||
| Identification and localization of Chlamydia pneumoniae in the Alzheimer's brain | Q28283487 | ||
| Herpes simplex virus type 1 in brain and risk of Alzheimer's disease | Q28302548 | ||
| Comparison of immunoglobulin G heavy-chain sequences in MS and SSPE brains reveals an antigen-driven response | Q30854079 | ||
| Chlamydia pneumoniae infection in circulating human monocytes is refractory to antibiotic treatment | Q31829380 | ||
| Genetic and Neurodevelopmental Influences in Autistic Disorder | Q33194174 | ||
| Under the microscope: focus on Chlamydia pneumoniae infection and multiple sclerosis | Q33320687 | ||
| Qualitative and quantitative detection of Chlamydophila pneumoniae DNA in cerebrospinal fluid from multiple sclerosis patients and controls | Q33428579 | ||
| Human herpesvirus 6: An emerging pathogen. | Q33643085 | ||
| Interlaboratory reliability of microimmunofluorescence test for measurement of Chlamydia pneumoniae-specific immunoglobulin A and G antibody titers | Q33711781 | ||
| Age-specific incidence rates of Alzheimer's disease: the Baltimore Longitudinal Study of Aging. | Q51976760 | ||
| Projections of Alzheimer's disease in the United States and the public health impact of delaying disease onset. | Q53224110 | ||
| A survey of mycoplasma detection in veterinary vaccines | Q69709114 | ||
| Continual breakdown and regeneration of myelin in progressive multiple sclerosis plaques | Q70974898 | ||
| HIV infection and dementia | Q73485402 | ||
| Association of HSV1 and apolipoprotein E-varepsilon4 in Alzheimer's disease | Q77158998 | ||
| High prevalence of Mycoplasma infections among European chronic fatigue syndrome patients. Examination of four Mycoplasma species in blood of chronic fatigue syndrome patients | Q78493851 | ||
| Multiple sclerosis and Chlamydia pneumoniae | Q43427368 | ||
| Chlamydia: a role for multiple sclerosis or more confusion? | Q43428225 | ||
| Chlamydia pneumonia and meningoencephalitis. | Q43433125 | ||
| Guillain-Barré syndrome after Chlamydia pneumoniae infection | Q43435375 | ||
| Relapsing-remitting multiple sclerosis and human herpesvirus 6 active infection. | Q43991039 | ||
| Broad expression of Toll-like receptors in the human central nervous system | Q44492400 | ||
| Alzheimer's disease--a spirochetosis? | Q44747732 | ||
| Minocycline reduces gadolinium-enhancing magnetic resonance imaging lesions in multiple sclerosis. | Q44880234 | ||
| Epstein-Barr virus and multiple sclerosis: evidence of association from a prospective study with long-term follow-up | Q45417845 | ||
| Presence of Epstein-Barr virus and human herpesvirus 6B DNA in multiple sclerosis patients: associations with disease activity | Q45422626 | ||
| Unconventional virus infection and neurological disease | Q45830989 | ||
| The curious case of clioquinol | Q46059338 | ||
| Possible association between congenital cytomegalovirus infection and autistic disorder | Q48205787 | ||
| A study of viral genomes and antigens in brains of patients with Alzheimer's disease | Q48228846 | ||
| Inflammation, A beta deposition, and neurofibrillary tangle formation as correlates of Alzheimer's disease neurodegeneration | Q48910098 | ||
| Autistic spectrum disorder: a child population profile | Q50308429 | ||
| The Diagnostic Interview for Social and Communication Disorders: background, inter-rater reliability and clinical use. | Q50309923 | ||
| Autism and infection/immunization episodes in Japan. | Q50311090 | ||
| Chlamydia pneumoniae infection associated with enhanced MRI spinal lesions in multiple sclerosis | Q37871138 | ||
| Serum immunoglobulin G antibodies to chlamydial heat shock protein 60 but not to human and bacterial homologs are associated with coronary artery disease. | Q37871182 | ||
| Is Chlamydia pneumoniae found in spinal fluid samples from multiple sclerosis patients? Conflicting results | Q37871479 | ||
| Failure to correlate C. pneumoniae with late onset Alzheimer's disease | Q37871632 | ||
| Association between seropositivity to Chlamydia pneumoniae and acute ischaemic stroke | Q37872032 | ||
| Autoimmunity to human heat shock protein 60, Chlamydia pneumoniae infection, and inflammation in predicting coronary risk | Q37872383 | ||
| Chlamydia pneumoniae in the cerebrospinal fluid of patients with multiple sclerosis and neurological controls | Q37872756 | ||
| Association between infection with Helicobacter pylori and Chlamydia pneumoniae and risk of ischemic stroke subtypes: Results from a population-based case-control study | Q37873296 | ||
| Encephalitis associated with Chlamydia pneumoniae | Q37873974 | ||
| Intrathecal antibody production against Chlamydia pneumoniae in multiple sclerosis is part of a polyspecific immune response | Q37874029 | ||
| Presence of Chlamydia pneumoniae DNA in the cerebral spinal fluid is a common phenomenon in a variety of neurological diseases and not restricted to multiple sclerosis | Q37874186 | ||
| PCR-based method for isolation and detection of Chlamydia pneumoniae DNA in cerebrospinal fluids | Q37874307 | ||
| Chlamydia pneumoniae in multiple sclerosis: humoral immune responses in serum and cerebrospinal fluid and correlation with disease activity marker | Q37874332 | ||
| Distribution of Chlamydia pneumoniae in the human arterial system and its relation to the local amount of atherosclerosis within the individual | Q37874544 | ||
| Chlamydia pneumoniae-associated ADEM. | Q37875762 | ||
| Chlamydia pneumoniae and the risk of first ischemic stroke : The Northern Manhattan Stroke Study | Q37876105 | ||
| Chlamydia pneumoniae serology: interlaboratory variation in microimmunofluorescence assay results | Q37876389 | ||
| Evidence for infection with Chlamydia pneumoniae in a subgroup of patients with multiple sclerosis | Q37876593 | ||
| Failure to detect Chlamydia pneumoniae in the central nervous system of patients with MS. | Q37877202 | ||
| Severe meningoencephalitis: an unusual manifestation of Chlamydia pneumoniae infection | Q37877234 | ||
| Failure to detect Chlamydia pneumoniae in brain tissues of Alzheimer's disease | Q37877411 | ||
| Frequency of apolipoprotein E (APOE) allele types in patients with Chlamydia-associated arthritis and other arthritides | Q37879150 | ||
| High prevalence of Chlamydia pneumoniae DNA in peripheral blood mononuclear cells in patients with cardiovascular disease and in middle-aged blood donors. | Q37880679 | ||
| Multiple sclerosis associated with Chlamydia pneumoniae infection of the CNS. | Q37881519 | ||
| Neurological complications of chlamydial infections: case report and review | Q37881980 | ||
| Epidemiology of encephalitis in children. A prospective multicentre study | Q37882554 | ||
| Association of chlamydial infection with cerebrovascular disease | Q37884018 | ||
| An unusual manifestation of Chlamydia pneumoniae infection: meningitis, hepatitis, iritis and atypical erythema nodosum | Q37891729 | ||
| Outbreak of Chlamydia pneumoniae infection in four farm families | Q37892941 | ||
| Lumbosacral meningoradiculitis associated with Chlamydia pneumoniae infection. | Q37893041 | ||
| A clinical and epidemiological study of "ornithosis" caused by Chlamydia psittaci and Chlamydia pneumoniae (strain TWAR). | Q37899165 | ||
| Serological evidence of an association of a novel Chlamydia, TWAR, with chronic coronary heart disease and acute myocardial infarction | Q37899465 | ||
| Epidemics of pneumonia caused by TWAR, a new Chlamydia organism, in military trainees in Finland | Q37900395 | ||
| A sero-epidemiological study of conventional infectious agents in Alzheimer's disease | Q37901205 | ||
| Incidence of Alzheimer disease in a biracial urban community: relation to apolipoprotein E allele status | Q39641831 | ||
| Incidence and etiology of dementia in a large elderly Italian population | Q40424138 | ||
| The clinical epidemiology of Alzheimer's disease | Q40940214 | ||
| The viral hypothesis of Alzheimer's disease. Absence of antibodies to lentiviruses | Q41223737 | ||
| The search for virus in multiple sclerosis brain | Q41622000 | ||
| Identification of Epstein-Barr virus proteins as putative targets of the immune response in multiple sclerosis | Q41788436 | ||
| Antimicrobial treatment of multiple sclerosis | Q43416436 | ||
| International conference on chlamydial and Mycoplasma human infections | Q43416566 | ||
| Real time PCR for detection of Chlamydophila pneumoniae in peripheral blood mononuclear cells of patients with multiple sclerosis | Q43416935 | ||
| Chlamydia pneumoniae, stroke, and serological associations: anything learned from the atherosclerosis-cardiovascular literature or do we have to start over again? | Q43418669 | ||
| Failure to detect Chlamydia pneumoniae in the central nervous system of patients with MS. | Q43424813 | ||
| No evidence of CNS infection with Chlamydia pneumoniae in patients with multiple sclerosis | Q43424853 | ||
| Meningoencephalitis and Chlamydia pneumoniae infection | Q43426269 | ||
| Lack of Chlamydia infection of the central nervous system in multiple sclerosis | Q43426524 | ||
| Is Chlamydia pneumoniae present in the central nervous system of multiple sclerosis patients? | Q43426528 | ||
| Mistaken self, a novel model that links microbial infections with myelin-directed autoimmunity in multiple sclerosis | Q33860689 | ||
| Chlamydia pneumoniae infection of the central nervous system in multiple sclerosis | Q33867663 | ||
| Chronic Chlamydia pneumoniae infection: a treatable cause of chronic fatigue syndrome | Q33873239 | ||
| Chlamydia pneumoniae and atherosclerosis: critical assessment of diagnostic methods and relevance to treatment studies | Q33905858 | ||
| Chlamydial virulence determinants in atherogenesis: the role of chlamydial lipopolysaccharide and heat shock protein 60 in macrophage-lipoprotein interactions | Q33935055 | ||
| Antibodies to 60-kilodalton heat shock protein and outer membrane protein 2 of Chlamydia pneumoniae in patients with coronary heart disease | Q33941659 | ||
| Lipopolysaccharide induction of gene expression in human monocytic cells | Q33942067 | ||
| Failure to detect Chlamydia pneumoniae in the late-onset Alzheimer's brain | Q33968146 | ||
| Analytical sensitivity, reproducibility of results, and clinical performance of five PCR assays for detecting Chlamydia pneumoniae DNA in peripheral blood mononuclear cells | Q33968165 | ||
| Is Chlamydia pneumoniae present in brain lesions of patients with multiple sclerosis? | Q33970414 | ||
| Comparative study of the presence of Chlamydia pneumoniae in cerebrospinal fluid of Patients with clinically definite and monosymptomatic multiple sclerosis | Q34174788 | ||
| Infection with Chlamydia pneumoniae and risk of multiple sclerosis | Q34180015 | ||
| Chlamydia pneumoniae infection of the central nervous system | Q34260373 | ||
| A randomized, controlled trial of doxycycline and rifampin for patients with Alzheimer's disease | Q34298526 | ||
| Standardizing Chlamydia pneumoniae assays: recommendations from the Centers for Disease Control and Prevention (USA) and the Laboratory Centre for Disease Control (Canada). | Q34312881 | ||
| Infectious causes of multiple sclerosis | Q34396144 | ||
| Pilot study to examine the effect of antibiotic therapy on MRI outcomes in RRMS. | Q34423729 | ||
| Role of infection in Alzheimer's disease | Q34496460 | ||
| Chlamydia pneumoniae and vascular disease: an update | Q34536607 | ||
| Chlamydia pneumoniae infection and the risk of multiple sclerosis: a meta-analysis | Q34556018 | ||
| Evidence for infectious agents in cardiovascular disease and atherosclerosis | Q34562273 | ||
| Revised estimate of the prevalence of multiple sclerosis in the united states | Q34563612 | ||
| Infection and the etiology and pathogenesis of multiple sclerosis | Q34566451 | ||
| Human herpes virus 6 and multiple sclerosis | Q34722813 | ||
| Chlamydial infections of the cardiovascular system | Q35011145 | ||
| Genetics of childhood disorders: XLVI. Autism, part 5: genetics of autism | Q35033724 | ||
| Chlamydia uncloaked | Q35167017 | ||
| Current status of metals as therapeutic targets in Alzheimer's disease | Q35188499 | ||
| Chlamydia pneumoniae (TWAR). | Q35367697 | ||
| Chlamydophila pneumoniae infection of the central nervous system in patients with multiple sclerosis. | Q35560428 | ||
| Association of Chlamydia pneumoniae with central nervous system disease | Q35586480 | ||
| Chlamydia pneumoniae--an infectious risk factor for atherosclerosis? | Q35701591 | ||
| Challenges and directions for the pathogen hypothesis of Alzheimer's disease. | Q35789654 | ||
| Human herpesvirus type 6 and multiple sclerosis | Q35866577 | ||
| Chlamydia and apoptosis: life and death decisions of an intracellular pathogen. | Q35892057 | ||
| Involvement of Chlamydia pneumoniae in atherosclerosis: more evidence for lack of evidence | Q36000970 | ||
| MSRV/HERV-W/syncytin and its linkage to multiple sclerosis: the usability and the hazard of a human endogenous retrovirus | Q36203760 | ||
| Cerebrospinal fluid analysis in the diagnosis of multiple sclerosis | Q36363875 | ||
| Association of Chlamydia pneumoniae infection with HLA-B*35 in patients with coronary artery disease | Q36422568 | ||
| The role of EBV in MS pathogenesis. | Q36458710 | ||
| The pathology of multiple sclerosis: a paradigm shift | Q36479913 | ||
| Multiple sclerosis: an infectious syndrome involving Chlamydophila pneumoniae | Q36601700 | ||
| Role of toll-like receptors in immune responses to chlamydial infections | Q37108497 | ||
| Initial characterization of Chlamydophila (Chlamydia) pneumoniae cultured from the late-onset Alzheimer brain | Q37315230 | ||
| Chlamydia pneumoniae DNA is present in peripheral blood mononuclear cells during acute coronary syndrome and correlates with chlamydial lipopolysaccharide levels in serum | Q37855685 | ||
| Chlamydophila pneumoniae DNA and mRNA transcript levels in peripheral blood mononuclear cells and cerebrospinal fluid of patients with multiple sclerosis. | Q37857227 | ||
| Molecular detection of Parachlamydia-like organisms in cerebrospinal fluid of patients with multiple sclerosis | Q37857269 | ||
| Anti-chlamydophila pneumoniae antibodies as associated factor for carotid atherosclerosis in patients with AIDS. | Q37857494 | ||
| Elevated levels of anti-Chlamydia pneumoniae IgA and IgG antibodies in young adults with ischemic stroke. | Q37859197 | ||
| The investigation of Chlamydophila pneumoniae in patients with multiple sclerosis. | Q37860203 | ||
| Chlamydophila (Chlamydia) pneumoniae in the Alzheimer's brain | Q37861147 | ||
| Role of chlamydia infection in the pathogenesis of atherosclerotic plaques in HIV-1-positive patients. | Q37862222 | ||
| Seropositivity to Chlamydia pneumoniae is associated with risk of first ischemic stroke | Q37863096 | ||
| Can meningoencephalitis be caused by Chlamydiae pneumoniae? | Q37863308 | ||
| Analysis of Chlamydia pneumoniae-specific oligoclonal bands in multiple sclerosis and other neurologic diseases | Q37863995 | ||
| Detection of chlamydial bodies and antigens in the central nervous system of patients with multiple sclerosis | Q37864046 | ||
| The load of Chlamydia pneumoniae in the Alzheimer's brain varies with APOE genotype | Q37864470 | ||
| High risk of schizophrenia and other mental disorders associated with chlamydial infections: hypothesis to combine drug treatment and adoptive immunotherapy | Q37864729 | ||
| Azithromycin for the secondary prevention of coronary events | Q37865023 | ||
| Chlamydia pneumoniae infection in HIV-positive patients: prevalence and relationship with lipid profile. | Q37865648 | ||
| Cerebrospinal fluid molecular demonstration of Chlamydia pneumoniae DNA is associated to clinical and brain magnetic resonance imaging activity in a subset of patients with relapsing-remitting multiple sclerosis | Q37866587 | ||
| Increased prevalence of and gene transcription by Chlamydia pneumoniae in cerebrospinal fluid of patients with relapsing-remitting multiple sclerosis | Q37867086 | ||
| A prospective study of Chlamydia pneumoniae infection and risk of MS in two US cohorts | Q37867101 | ||
| Chlamydia pneumoniae infection in young stroke patients: a case--control study | Q37867152 | ||
| First-choice antibiotics at subinhibitory concentrations induce persistence of Chlamydia pneumoniae | Q37867494 | ||
| Chlamydia pneumoniae induces Alzheimer-like amyloid plaques in brains of BALB/c mice | Q37867591 | ||
| Intrathecal production of Chlamydia pneumoniae-specific high-affinity antibodies is significantly associated to a subset of multiple sclerosis patients with progressive forms. | Q37867930 | ||
| Chlamydia pneumoniae and the risk for exacerbation in multiple sclerosis patients | Q37868000 | ||
| An MRI study of Chlamydia pneumoniae infection in Italian multiple sclerosis patients. | Q37868355 | ||
| Detection of Chlamydia pneumoniae in the cerebrospinal fluid of patients with multiple sclerosis by combination of cell culture and PCR: no evidence for possible association | Q37868453 | ||
| Absence of Chlamydia pneumoniae in brain of vascular dementia patients | Q37868777 | ||
| Chlamydia pneumoniae in children with MS: frequency and quantity of intrathecal antibodies | Q37869076 | ||
| Chlamydia pneumoniae DNA in patients with symptomatic carotid atherosclerotic disease | Q37869411 | ||
| Molecular identification and antibody testing of Chlamydophila pneumoniae in a subgroup of patients with HIV-associated dementia complex. Preliminary results | Q37869968 | ||
| Chlamydia pneumoniae infection promotes the transmigration of monocytes through human brain endothelial cells | Q37870146 | ||
| Chlamydia pneumoniae infection alters the junctional complex proteins of human brain microvascular endothelial cells | Q37870583 | ||
| Reliability of nested PCR for detection of Chlamydia pneumoniae DNA in atheromas: results from a multicenter study applying standardized protocols | Q37870755 | ||
| Chlamydial heat-shock protein-60 antibody and correlation with Chlamydia pneumoniae in atherosclerotic plaques | Q37870954 | ||
| P275 | copyright license | Creative Commons Attribution 3.0 Unported | Q14947546 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P921 | main subject | Chlamydophila pneumoniae | Q132319 |
| P304 | page(s) | 273573 | |
| P577 | publication date | 2010-02-21 | |
| P1433 | published in | Interdisciplinary Perspectives on Infectious Diseases | Q26842016 |
| P1476 | title | Chlamydophila pneumoniae Infection and Its Role in Neurological Disorders | |
| P478 | volume | 2010 |
| Q38078463 | A Sardinian map for multiple sclerosis |
| Q38742869 | A prolonged antibiotic protocol to treat persistent Chlamydophila pneumoniae infection improves the extracranial venous circulation in multiple sclerosis |
| Q91928938 | An agent-based model to investigate microbial initiation of Alzheimer's via the olfactory system |
| Q64912466 | Chlamydiaceae: Diseases in Primary Hosts and Zoonosis. |
| Q92006574 | Comparative in silico analysis of ftsZ gene from different bacteria reveals the preference for core set of codons in coding sequence structuring and secondary structural elements determination |
| Q35261754 | Different presence of Chlamydia pneumoniae, herpes simplex virus type 1, human herpes virus 6, and Toxoplasma gondii in schizophrenia: meta-analysis and analytical study. |
| Q37849808 | Endemic and emerging chlamydial infections of animals and their zoonotic implications |
| Q26781578 | Herpes Simplex Virus Type 1 and Other Pathogens are Key Causative Factors in Sporadic Alzheimer's Disease |
| Q35502254 | Human blood monocytes support persistence, but not replication of the intracellular pathogen C. pneumoniae |
| Q40044431 | Interactions of antisera to different Chlamydia and Chlamydophila species with the ribosomal protein RPS27a correlate with impaired protein synthesis in a human choroid plexus papilloma cell line |
| Q33949413 | Isolation of Chlamydia pneumoniae from serum samples of the patients with acute coronary syndrome. |
| Q43410437 | Jugulodigastric lymph node inflammation derived from chronic atypical oropharyngeal phlogosis recurring annually after flu virus vaccination: a holistic vision of a clinical case solved after chlamydicidal antibiotic therapy |
| Q47404070 | Review: Impact of Helicobacter pylori on Alzheimer's disease: What do we know so far? |
| Q33641235 | The neurological disease ontology |
| Q64108432 | is present in the dental plaque of periodontitis patients and stimulates an inflammatory response in gingival epithelial cells |
Search more.